Search results for "From ACP Journal Club"


 
Results 41 - 50 of about 129 for "From ACP Journal Club".

Review: Metformin is linked to reduced mortality in type 2 diabetes with comorbid CKD and CHF | ACP Diabetes Monthly

The included studies focused on metformin use in patients with chronic kidney disease (CKD), congestive heart failure (CHF), chronic liver disease (CLD), or older age.

October 7, 2016 | ACP Diabetes Monthly

ACP Diabetes Monthly delivers a monthly summary of news about diabetes, including the latest research, clinical guidelines, and FDA drug actions.

February 14, 2014 | ACP Diabetes Monthly

ACP Diabetes Monthly delivers a monthly summary of news about diabetes, including the latest research, clinical guidelines, and FDA drug actions.

April 10, 2015 | ACP Diabetes Monthly

ACP Diabetes Monthly delivers a monthly summary of news about diabetes, including the latest research, clinical guidelines, and FDA drug actions.

Review: Intensive blood pressure control reduces retinopathy in diabetes | ACP Diabetes Monthly

Intensive control of blood pressure reduced incidence of retinopathy, but not progression of established retinopathy, in patients with type 1 or 2 diabetes, according to an analysis of 15 randomized controlled trials.

In patients with type 2 diabetes and CVD, empagliflozin reduced incident or worsening nephropathy at 3.1 y | ACP Diabetes Monthly

A subanalysis of a trial of empagliflozin for patients with cardiovascular disease (CVD) found lower rates of nephropathy in those randomized to empagliflozin rather than placebo.

March 14, 2014 | ACP Diabetes Monthly

ACP Diabetes Monthly delivers a monthly summary of news about diabetes, including the latest research, clinical guidelines, and FDA drug actions.

In type 1 diabetes, adding liraglutide to insulin increased hypoglycemia and hyperglycemia with ketosis | ACP Diabetes Monthly

The study authors concluded that the negative effects observed would limit clinical use of liraglutide in patients with type 1 diabetes.

Self-monitoring of blood glucose did not improve HbA1c or QOL at 1 year in non-insulin-treated type 2 diabetes | ACP Diabetes Monthly

The randomized controlled trial adds to the evidence about routine use of self-monitoring of blood glucose for all patients with type 2 diabetes, according to an ACP Journal Club commentary.

June 8, 2018 | ACP Diabetes Monthly

ACP Diabetes Monthly delivers a monthly summary of news about diabetes, including the latest research, clinical guidelines, and FDA drug actions.

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next